Cost-Effectiveness of Exenatide Once Weekly Versus Insulin Glargine and Liraglutide for the Treatment of Type 2 Diabetes in Greece
Abstract
Authors
C Tzanetakos A Bargiota G Kourlaba N Maniadakis
C Tzanetakos A Bargiota G Kourlaba N Maniadakis
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now